Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results

Sun Hyun Bae; Won Il Jang; Hee Chul Park

doi:10.18632/oncotarget.19219

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results

Sun Hyun Bae, Won Il Jang and Hee Chul Park _

PDF | HTML | How to cite

Oncotarget. 2017; 8:59965-59976. https://doi.org/10.18632/oncotarget.19219

Metrics: PDF 1585 views | HTML 2268 views | ?

Abstract

Sun Hyun Bae1,*, Won Il Jang2,* and Hee Chul Park3,4

1Department of Radiation Oncology, Soonchunhyang University College of Medicine, Bucheon, Korea

2Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences, Seoul, Korea

3Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

4Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul, Korea

*These authors contributed equally to this work

Correspondence to:

Hee Chul Park, email: [email protected]

Keywords: conformal radiotherapy, hepatocellular carcinoma, intensity-modulated radiotherapy, radiotherapy

Received: January 23, 2017 Accepted: June 02, 2017 Published: July 13, 2017

ABSTRACT

Since the introduction of 3-dimensional conformal radiotherapy (3DCRT), new radiotherapy techniques have expanded the indication of radiotherapy for the treatment of hepatocellular carcinoma (HCC), from the hitherto palliative to a now curative-intent purpose. Intensity-modulated radiotherapy (IMRT), currently the most advanced radiotherapy technique, is considered an attractive option for the treatment of HCC, and is more widely applied because it can deliver a higher dose to the tumor than 3DCRT while sparing surrounding normal organs. However, the advantages and potential disadvantages of IMRT for treating HCC have not been fully established. This article deals with three different IMRT techniques, including static IMRT and volumetric modulated arc therapy using conventional multileaf collimator (MLC) mounted linear accelerators, and helical IMRT using binary MLC mounted helical tomotherapy machine. We review dosimetric and clinical studies for these IMRT techniques for the treatment of HCC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19219

Publication Alerts

Reviews:

Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results

Abstract